title: Moving forward with human papillomavirus immunotherapies.
abstract: Persistent human papillomavirus (HPV) is the primary etiologic agent of cervical cancer and causes a significant number of vulvar, penile, anal and oropharyngeal cancers. The development of highly effective HPV therapeutic vaccines is a reasonable goal given the recent advances in basic and applied immunology. A number of vaccine strategies designed to induce systemic T cell responses have been tested in clinical trials against high grade cervical or vulvar high grade neoplasia and cancers, but with limited success. In line with the emerging trend to focus more on the epithelial context of HPV infection and premalignant disease, it might be advantageous to develop vaccination strategies that promote trafficking of HPV-specific T cells into lesions and overcome the local immunosuppressive environment. The development of more biologically relevant animal models would improve the preclinical evaluation of therapeutic vaccine candidates. Finally, persistent infection and low grade lesions may prove to be easier targets for therapeutic vaccines, and these vaccines would likely be commercially viable in high income countries and valuable components in screen and treat programs in low resource settings.
authors.affiliation: a Laboratory of Cellular Oncology , Center for Cancer Research, National Cancer Institute, NIH , Bethesda , MD , USA.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Çuburu
authors.affiliation: a Laboratory of Cellular Oncology , Center for Cancer Research, National Cancer Institute, NIH , Bethesda , MD , USA.
authors.forename: John T
authors.initials: JT
authors.lastname: Schiller
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D030361:Papillomavirus Infections / Q000150:complications / Q000628:therapy*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000628:therapy*
chemical_list: D053918:Papillomavirus Vaccines
keywords: Human papillomavirus; cancer; immunotherapy; mucosal immunity; therapeutic vaccines